Particle Therapy Market is expected to reach a market valuation of USD 2.6 billion in 2034
Particle therapy market is
expected to reach a market valuation of USD 2.6 billion in 2034, with a
compound annual growth rate (CAGR) of 7.6% from 2024 to 2034. The market was
valued at over USD 1.5 billion in 2023. Particle treatment enhances disease
control and lessens damage to healthy tissue. The market is increasing and
sustainable since it is in line with the healthcare industry.
Particle therapy is an external beam radiation modality
used primarily to treat malignant tumors with protons. Technically speaking,
hadron therapy is another name for particle therapy. The majority of particle
beam radiation used in this therapy is delivered precisely and has special
physical properties that reduce collateral damage to healthy tissues. This
characteristic is especially important for tumors that are not spreading to
other body sections but are situated close to important structures.
Request
For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/particle-therapy-market
GROWTH DRIVERS
The biggest factor propelling the market's growth is the
rise in cancer prevalence worldwide. 20 million new instances of cancer and 9.7
million deaths from cancer are reported worldwide in the International Agency
for Research on Cancer (IARC) 2022 report, with lung and breast cancer being
the most common types of the disease. Furthermore, it is predicted that by
2050, there will be 35 million instances of cancer worldwide, with low- and
middle-income nations accounting for the majority of these cases. This
underscores the need for enhanced healthcare infrastructure and affordable
cancer services.
Additionally, the Wisconsin Alumni Research Foundation
provided a seed investment of USD 1.5 million and the National Cancer Institute
awarded them a grant of USD 20 million. According to the American Cancer
Society database, 39.6% of women and 41.6% of men are predicted to develop
cancer over their lifetime. This statistic highlights the increased incidence
of cancer associated with an aging population. People 65 years of age and older
receive diagnoses for about two thirds of all new cases. According to the UN,
the proportion of people over 65 in the world is predicted to increase from 10%
in 2022 to 16% in 2050. Thus, the market's growth is driven by the aging
population.
MARKET
SEGMENTATION:
· By
Therapy Type- proton therapy (cyclotron and synchrotrons), heavy-ion
therapy and hybrid particle therapy
· By
Room Configuration Type- single room and multi room
· By
Application- research and treatment
· By
Cancer Type- pediatric cancer, breast cancer, lung cancer, prostate cancer,
colorectal cancer, liver cancer and others
· By
Region- North America, Europe, Asia Pacific, Middle & Africa and
South America
Global Key
Players:
· IBA
Worldwide
· Varian
Medical Systems
· Hitachi
· Mevion
Medical Systems
· Optivus
Proton Therapy
· Sumitomo
Heavy Industries, Ltd.
· Danfysik
A/S
· Provision
Healthcare
· Other
Players
For
More Information about this Report @ https://www.xresearch.biz/shop/particle-therapy-market
About
Us: -
xResearch is a
market research and consulting organization that uses unique data, expert
analysis, and new technologies to create trusted intelligence on industries.
Our research is focused on delivering an informed and impartial view on
essential market data of industry, and it is primarily driven by an in-depth
study covering the following parameters: Market Sizing and Forecasting, Market
Segmentation, Competitive Analysis, Strategic Assessment and Business Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-619-8140
Comments
Post a Comment